Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Kao Corporation KAOCF OTC

Other OTC • Consumer Defensive • Household & Personal Products • JP • USD

SharesGrow Score
82/100
5/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Kao Corporation (KAOCF) is a Household & Personal Products company in the Consumer Defensive sector, currently trading at $39.60. It has a SharesGrow Score of 80/100, indicating a strong investment profile with 5 out of 7 criteria passed.

Financials: revenue is $1.7T, +3%/yr average growth. Net income is $120.2B, growing at +36.1%/yr. Net profit margin is 7.1% (thin). Gross margin is 38% (+2.6 pp trend).

Balance sheet: total debt is $334.0B against $1.1T equity (Debt-to-Equity (D/E) ratio 0.31, conservative). Current ratio is 1.75 (strong liquidity). Debt-to-assets is 17.8%. Total assets: $1.9T.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 73/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 74/100 (Pass), Future ?/100 (Fail), Income 45/100 (Partial).

KAOCF SharesGrow Score Overview

82/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 74/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — KAOCF

✓
VALUE Pass
100/100
KAOCF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
73/100
KAOCF: +3%/yr revenue is, +36.1%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
KAOCF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet KAOCF: Debt-to-Equity (D/E) ratio 0.31 (conservative), Current ratio is 1.75 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✓
MOAT Pass
74/100
KAOCF: Gross margin is 38% (+2.6 pp trend), $18B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 74/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
~
INCOME Partial
45/100
KAOCF: Net profit margin is 7.1%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range36.96-49.59
Volume100
Avg Volume (30D)561
Market Cap$17.91B
Beta (1Y)0.19
Dividend Yield$0.9259
Share Statistics
EPS (TTM)260.53
Shares Outstanding$461.32M
IPO Date2012-01-17
Employees32,566
CEOYoshihiro Hasebe
Financial Highlights & Ratios
Revenue (TTM)$1.69T
Gross Profit$641.54B
EBITDA$256.33B
Net Income$120.19B
Operating Income$163.18B
Total Cash$323.56B
Total Debt$334.04B
Net Debt$10.48B
Total Assets$1.88T
Price / Earnings (P/E)0.2
Price / Sales (P/S)0.01
Analyst Forecast
Company Info
CountryJP
ExchangeOther OTC
CurrencyUSD
ISINJP3205800000

Price Chart

Track all markets on TradingView
KAOCF
Kao Corporation ↗  ·  Other OTC
Consumer Defensive • Household & Personal Products
36.96 52WK RANGE 49.59

People Also View

PG
PG
The Procter & Gamble Company
$144.40
+0.57%
 UL
UL
Unilever PLC
$57.81
-0.72%
 CL
CL
Colgate-Palmolive Company
$84.16
+0.21%
 KMB
KMB
Kimberly-Clark Corporation
$97.16
+0.58%
 EL
EL
The Estée Lauder Companies Inc.
$76.42
+2.51%
 CLX
CLX
The Clorox Company
$104.44
+1.02%
 UNICY
UNICY
Unicharm Corporation
$3.05
-0.29%
 HIMS
HIMS
Hims & Hers Health, Inc.
$21.36
+0.99%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message